Építés alatt – nem éles oldal
Belépés
Taking people in Hollandia2. fázis

Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemic Treatment for early-stage REctal Cancer?

Key facts

Where
Amsterdam, Arnhem, Breda, Capelle aan den IJssel, Deventer, Eindhoven, Groningen, Hoofddorp, Leeuwarden, Leiden, Maastricht, Nijmegen, Rotterdam, Tilburg, Utrecht és Zwolle, HollandiaSee the 24 sites
Phase
2. fázis

Where in Hollandia

  • Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis StichtingAmsterdam, HollandiaTaking people
  • Stichting Amsterdam UMCAmsterdam, HollandiaTaking people
  • Stichting OLVGAmsterdam, HollandiaTaking people
  • RadiotherapiegroepArnhem, HollandiaTaking people
  • Rijnstate Ziekenhuis StichtingArnhem, HollandiaTaking people
  • Amphia HospitalBreda, HollandiaTaking people
  • IJsselland ZiekenhuisCapelle aan den IJssel, HollandiaTaking people
  • Deventer ZiekenhuisDeventer, HollandiaTaking people
  • Catharina Ziekenhuis StichtingEindhoven, HollandiaTaking people
  • Stichting Martini ZiekenhuisGroningen, HollandiaTaking people
  • Universitair Medisch Centrum GroningenGroningen, HollandiaTaking people
  • Spaarne Gasthuis StichtingHoofddorp, HollandiaTaking people
  • Medisch Centrum Leeuwarden B.V.Leeuwarden, HollandiaTaking people
  • Radiotherapeutisch Instituut FrieslandLeeuwarden, HollandiaTaking people
  • Leids Universitair Medisch Centrum (LUMC)Leiden, HollandiaTaking people
  • Maastricht University Medical Center+ (MUMC+)Maastricht, HollandiaTaking people
  • MaastroMaastricht, HollandiaTaking people
  • Radboud Universitair Medisch Centrum (Radboudumc)Nijmegen, HollandiaTaking people
  • Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)Rotterdam, HollandiaTaking people
  • Dr. Bernard Verbeeten Instituut StichtingTilburg, HollandiaTaking people
  • Stichting Elisabeth-TweeSteden ZiekenhuisTilburg, HollandiaTaking people
  • Diakonessenhuis StichtingUtrecht, HollandiaTaking people
  • Universitair Medisch Centrum UtrechtUtrecht, HollandiaTaking people
  • Isala Klinieken StichtingZwolle, HollandiaTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Radboud universitair medisch centrum Stichting
Trial code
EU 2024-514620-17-00
Record updated
2026. október 8.
Original description
The assessment of successful organ preservation rates in the concerning study arms.Read full original descriptionShow less

STARTREC - Can we Save the rectum by watchful waiting or transanal surgery following short- or long-course radioTherapy and Additional local oR systemic Treatment for early-stage REctal Cancer?

The assessment of successful organ preservation rates in the concerning study arms.

Inclusion: Biopsy proven adenocarcinoma of the rectum; Early- or early-intermediate stage rectal cancer, defined as Magnetic Resonance Imaging (MRI)-T1-3ab, N0/N1 (≤3 mesorectal lymph nodes ≤8mm), MX/M0 rectal tumour; Tumour located in the distal or mid-rectum for which TME-surgery is required; Eastern Cooperative Oncology Group (ECOG) performance status 0-1; Age 18 years or older; Patient able and willing to provide written informed consent for the study.

Exclusion: Tumour located in the proximal rectum for which PME-surgery will be sufficient; Any form of (endoscopic/surgical) local excision of the primary tumour prior to study-entry; Prior pelvic radiotherapy; Concomitant or previous malignancies within 3 years prior to trial entry, except those that in the opinion of the MDT are unlikely to relapse < 3 years or lead to death < 5 years; Definite evidence of regional or distant metastases (M1) in opinion of MDT; Pregnant or lactating women; Pre-existing faecal incontinence, leading to an expected impaired quality of life post-treatment; MRI suspicious lymph nodes cN1 (1-3 lymph nodes > 8mm) or cN2; MRI extramural vascular invasion (mriEMVI) present (defined by protocol guidelines); MRI defined mucinous tumour; Mesorectal fascia threatened by tumour (≤ 1mm on MRI).

EU CTIS 2024-514620-17-00